Suppr超能文献

头孢哌酮-舒巴坦对拟杆菌属细菌的体外活性。

In-vitro activity of cefoperazone-sulbactam against Bacteroides species.

作者信息

Souza Dias M B, Jacobus N V, Tally F P

出版信息

J Antimicrob Chemother. 1986 Oct;18(4):467-71. doi: 10.1093/jac/18.4.467.

Abstract

The in-vitro activity of two combinations of sulbactam and cefoperazone against 187 strains of Bacteroides fragilis were evaluated; their activity was compared with that of the drugs alone, and correlated with the production of beta-lactamase by the bacterial strains. The results indicated that both combinations had a synergistic effect: the addition of 8 mg/l of sulbactam to the MIC of cefoperazone reduced the percentage of resistant strains from 58% to 0.5%; while the combination of two parts of cefoperazone to one pact of sulbactam lowered the resistance rate to 1%. Synergy was observed most frequently with beta-lactamase positive strains, but it also occurred among beta-lactamase negative strains.

摘要

评估了舒巴坦与头孢哌酮两种组合对187株脆弱拟杆菌的体外活性;将它们的活性与单独使用药物的活性进行比较,并与菌株β-内酰胺酶的产生相关联。结果表明,两种组合均具有协同作用:在头孢哌酮的最低抑菌浓度(MIC)中添加8mg/l舒巴坦可使耐药菌株的百分比从58%降至0.5%;而头孢哌酮与舒巴坦以2:1组合可将耐药率降至1%。协同作用在β-内酰胺酶阳性菌株中最为常见,但在β-内酰胺酶阴性菌株中也会出现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验